Variant report
Variant | rs3729707 |
---|---|
Chromosome Location | chr19:55668992-55668993 |
allele | A/C |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:55666400-55669400 | Active TSS | Left Ventricle | heart |
2 | chr19:55667200-55669200 | Active TSS | Right Atrium | heart |
3 | chr19:55667400-55669000 | Bivalent/Poised TSS | ES-I3 Cell Line | embryonic stem cell |
4 | chr19:55667400-55669000 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
5 | chr19:55667400-55669000 | Bivalent Enhancer | Primary T killer naive cells fromperipheralblood | blood |
6 | chr19:55667400-55669000 | Flanking Bivalent TSS/Enh | Fetal Adrenal Gland | Adrenal Gland |
7 | chr19:55667400-55669000 | ZNF genes & repeats | Spleen | Spleen |
8 | chr19:55667400-55669200 | Active TSS | iPS-18 Cell Line | embryonic stem cell |
9 | chr19:55667400-55669400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
10 | chr19:55667400-55670000 | Bivalent Enhancer | Placenta | Placenta |
11 | chr19:55667600-55669000 | Active TSS | Fetal Heart | heart |
12 | chr19:55667800-55669200 | Bivalent Enhancer | Fetal Intestine Small | intestine |
13 | chr19:55667800-55669200 | Active TSS | Right Ventricle | heart |
14 | chr19:55668000-55669200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
15 | chr19:55668000-55669400 | Flanking Active TSS | K562 | blood |
16 | chr19:55668200-55669000 | Bivalent Enhancer | Monocytes-CD14+_RO01746 | blood |
17 | chr19:55668200-55669200 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr19:55668200-55669400 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
19 | chr19:55668200-55669600 | Weak transcription | Hela-S3 | cervix |
20 | chr19:55668200-55670000 | Weak transcription | Psoas Muscle | Psoas |
21 | chr19:55668400-55669000 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
22 | chr19:55668400-55669800 | Weak transcription | A549 | lung |
23 | chr19:55668600-55669000 | Flanking Bivalent TSS/Enh | HUES6 Cell Line | embryonic stem cell |
24 | chr19:55668600-55669000 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin03 | Skin |
25 | chr19:55668600-55669400 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
26 | chr19:55668600-55670600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
27 | chr19:55668600-55671600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
28 | chr19:55668600-55672000 | Weak transcription | Pancreas | Pancrea |
29 | chr19:55668800-55669000 | Flanking Bivalent TSS/Enh | H1 Cell Line | embryonic stem cell |
30 | chr19:55668800-55669000 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
31 | chr19:55668800-55669000 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
32 | chr19:55668800-55669200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
33 | chr19:55668800-55669400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
34 | chr19:55668800-55670800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
35 | chr19:55668800-55671600 | Weak transcription | H9 Cell Line | embryonic stem cell |